Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (31-40 of 364) with videos related to

Pageof 37
Sort By:
Inflammatory Bowel Diseases|September 26, 2008
Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Gut|June 20, 2014
Use of azathioprine in IBD: modern aspects of an old drugEdouard Louis, Peter Irving, Laurent Beaugerie
Revue Medicale De Liege|December 14, 2023
[Iatrogenic colitis following immunotherapy : monocentric retrospective study at the University Hospital of Liège]Fernand Weerts, Catherine Loly, Edouard Louis
World Journal of Gastroenterology|September 24, 2008
Are we giving biologics too much time? When should we stop treatment?Edouard Louis, J Belaiche, C Reenaers
World Journal of Gastroenterology|August 10, 2012
Impact of medical therapies on inflammatory bowel disease complication rateCatherine Reenaers, Jacques Belaiche, Edouard Louis
Journal of Crohn'S & Colitis|March 21, 2019
The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's DiseaseKristian Bolin, Erik Hertervig, Edouard Louis
Therapeutic Advances in Gastroenterology|December 25, 2010
Current directions of biologic therapies in inflammatory bowel diseaseCatherine Reenaers, Edouard Louis, Jacques Belaiche
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Scandinavian Journal of Gastroenterology|December 17, 2008
Predictors of severe Crohn's diseaseCatherine Loly, Jacques Belaiche, Edouard Louis
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Pageof 37

Showing results (31-40 of 364) with videos related to

Sort By:
Pageof 37
Inflammatory Bowel Diseases|September 26, 2008
Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Gut|June 20, 2014
Use of azathioprine in IBD: modern aspects of an old drugEdouard Louis, Peter Irving, Laurent Beaugerie
Revue Medicale De Liege|December 14, 2023
[Iatrogenic colitis following immunotherapy : monocentric retrospective study at the University Hospital of Liège]Fernand Weerts, Catherine Loly, Edouard Louis
World Journal of Gastroenterology|September 24, 2008
Are we giving biologics too much time? When should we stop treatment?Edouard Louis, J Belaiche, C Reenaers
World Journal of Gastroenterology|August 10, 2012
Impact of medical therapies on inflammatory bowel disease complication rateCatherine Reenaers, Jacques Belaiche, Edouard Louis
Journal of Crohn'S & Colitis|March 21, 2019
The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's DiseaseKristian Bolin, Erik Hertervig, Edouard Louis
Therapeutic Advances in Gastroenterology|December 25, 2010
Current directions of biologic therapies in inflammatory bowel diseaseCatherine Reenaers, Edouard Louis, Jacques Belaiche
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Scandinavian Journal of Gastroenterology|December 17, 2008
Predictors of severe Crohn's diseaseCatherine Loly, Jacques Belaiche, Edouard Louis
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Pageof 37